Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer
Yixiang Gu,
No information about this author
Ruifeng Yang,
No information about this author
Yang Zhang
No information about this author
et al.
Molecular Biomedicine,
Journal Year:
2025,
Volume and Issue:
6(1)
Published: Jan. 6, 2025
Cancer
remains
a
leading
cause
of
mortality
globally
and
major
health
burden,
with
chemotherapy
often
serving
as
the
primary
therapeutic
option
for
patients
advanced-stage
disease,
partially
compensating
limitations
non-curative
treatments.
However,
emergence
resistance
significantly
limits
its
efficacy,
posing
clinical
challenge.
Moreover,
heterogeneity
mechanisms
across
cancer
types
complicates
development
universally
effective
diagnostic
approaches.
Understanding
molecular
chemoresistance
identifying
strategies
to
overcome
it
are
current
research
focal
points.
This
review
provides
comprehensive
analysis
key
underlying
resistance,
including
drug
efflux,
enhanced
DNA
damage
repair
(DDR),
apoptosis
evasion,
epigenetic
modifications,
altered
intracellular
metabolism,
role
stem
cells
(CSCs).
We
also
examine
specific
causes
in
highlight
various
targets
involved
resistance.
Finally,
we
discuss
aiming
at
overcoming
such
combination
therapies,
targeted
treatments,
novel
delivery
systems,
while
proposing
future
directions
this
evolving
field.
By
addressing
these
barriers,
lays
foundation
more
therapies
aimed
mitigating
Language: Английский
Development and Validation of Monte Carlo Methods for Converay: A Proof-of-Concept Study
R. Figueroa,
No information about this author
Francisco Malano,
No information about this author
A. Cuadra
No information about this author
et al.
Cancers,
Journal Year:
2025,
Volume and Issue:
17(7), P. 1189 - 1189
Published: March 31, 2025
Radiotherapy
technology
has
undergone
significant
advancements,
driven
by
the
pursuit
of
improved
tumor
control
probabilities
and
reduced
normal
tissue
complication
probabilities.
This
been
achieved
primarily
through
innovative
approaches
that
prioritize
high
dose
conformity
on
complex
treatment
targets.
The
CONVERAY
project
introduces
a
groundbreaking
teletherapy
system
featuring
convergent
X-ray
beam,
which
enables
highly
conformal
distributions
converging
photons
to
focal
spot,
thereby
achieving
exceptionally
fluence
rates.
Customized
Monte
Carlo
subroutines
have
developed
simulate
particle
associated
dosimetry
effects
for
device.
simulation
approach
facilitated
detailed,
step-by-step
characterization
radiation
interaction
processes,
enabling
seamless
integration
with
conventional
clinical
linear
accelerator
head.
Key
physical
properties
beam
comprehensively
characterized
various
configurations,
providing
solid
foundation
evaluating
corresponding
performance.
simulations
successfully
tracked
phase
state
device,
characterizing
influence
individual
components
photon
production.
Simulations
evaluated
performance,
confirming
device's
capability
achieve
concentrations
around
spot.
Preliminary
tests
realistic
scenarios
(intracranial
pulmonary
irradiations)
demonstrated
promising
spatial
concentration
within
volumes,
while
gantry
rotation
significantly
conformation.
proof-of-concept
study
prototype
provided
critical
insights
into
generation
beams,
validating
ability
its
primary
objective.
Notably,
results
reveal
potential
demonstrating
Language: Английский
Surgical Outcomes of Minimally Invasive Lung Resection in Nonagenarians: A Retrospective Analysis of Seven Patients at a Single Institution
Takahiro Karasaki,
No information about this author
Sakashi Fujimori,
No information about this author
Souichiro Suzuki
No information about this author
et al.
Cureus,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 13, 2025
Language: Английский
A SiC Photo-Conductive Switch-Based Pulse Generator with Nanoseconds and High Voltage for Liver Cancer Cells Ablation Therapy
Haocheng Yin,
No information about this author
Zeyu Zhang,
No information about this author
Yapeng Liu
No information about this author
et al.
Electronics,
Journal Year:
2024,
Volume and Issue:
13(23), P. 4816 - 4816
Published: Dec. 6, 2024
Electroporation
ablation,
as
an
innovative
cancer
treatment,
not
only
preserves
the
structure
and
function
of
affected
organs
but
also
significantly
reduces
surgical
risks,
offers
patients
a
safer
more
effective
therapeutic
option,
demonstrates
immense
potential
in
field
oncology.
This
paper
presents
design
high-voltage
nanosecond
pulse
generator
triggered
by
silicon
carbide
(SiC)
photoconductive
switch.
The
is
capable
stably
outputting
adjustable
voltages
ranging
from
10
kV
to
15
kV,
with
widths
precisely
controlled
between
nanoseconds,
operating
frequency
1
Hz
Hz.
device
enables
instant
activation
deactivation
during
enhancing
efficiency
strong
electric
applications
preventing
overtreatment
due
delayed
shutdown.
introduces
basic
principles
this
novel
SiC
switch-triggered
reports
on
impact
device-related
parameters
ablation
effect
hepatocellular
carcinoma
cells
through
cell
experiments.
Under
optimal
parameters,
CCK8
results
show
that
number
viable
0.7%
untreated
control
group
after
12
h
subculture
following
ablation.
These
findings
hold
significant
importance
for
expanding
application
areas
devices.
Language: Английский